One pill to tackle two heart risks: triple combo tested

NCT ID NCT03860220

Completed Disease control Sponsor: Hyo-Soo Kim Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed Phase 4 trial tested a single pill containing three medicines (telmisartan, amlodipine, and rosuvastatin) in 252 Korean adults with both high blood pressure and high cholesterol. Participants took either the triple pill or a two-drug pill for 8 weeks. The study measured changes in blood pressure and LDL cholesterol to see if the triple combination works better.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Telmisartan/Amlodipine/Rosuvastatin (triple combination pill)
What this could lead to: If successful, this could offer a simpler once-daily pill to manage both high blood pressure and high cholesterol together.
What could go wrong: This is a completed Phase 4 trial, so results are already known. The main risk is that the triple pill may not be more effective or safer than existing two-drug combinations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DYSLIPIDEMIAS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Dyslipidemias hyperlipidemia hypertensive disorder inherited lipid metabolism disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DYSLIPIDEMIAS HYPERTENSION

Contacts and locations

Locations

CHA Bundang Medical Center, CHA University

Seongnam-si, Gyeonggi-do, 13496, South Korea
Hallym University Kangnam Sacred Heart Hospital

Seoul, South Korea
Hallym University Sacred Heart Hospital

Anyang-si, Gyeonggi-do, 14068, South Korea
Kangwon National University Hospital

Chuncheon, Gangwon-do, 24289, South Korea
Korea University Ansan Hospital

Ansan, Gyeonggi-do, 15355, South Korea
Kyung Hee University Hospital at Gangdong

Seoul, South Korea
Severance Hospital, Yonsei University Health System

Seoul, 03722, South Korea
Yeungnam University Hospital

Daegu, 42415, South Korea
Yonsei University Wonju Severance Christian Hospital

Wŏnju, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.